Clinical trial
Detection of Significant Coronary Artery Disease in Nephropathy Patients Utilizing Coronary CTA and Real Time Perfusion DSE: Comparison With Quantitative Coronary Angiography and Patient Outcome
NCT00726921 is registered in ClinicalTrials.gov with University of Nebraska as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Detection of Significant Coronary Artery Disease in Nephropathy Patients Utilizing Coronary CTA and Real Time Perfusion DSE: Comparison With Quantitative Coronary Angiography and Patient Outcome
- Lead sponsor
- University of Nebraska
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 25, 2008
- Completion date
- December 21, 2012
- Enrollment
- 189 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.